FAB classification M3 Acute Promyelocytic Leukemia

DBCOND0024172Bone Marrow Diseases Hematologic Neoplasms

FAB classification M3 Acute Promyelocytic Leukemia is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Classified under: Bone Marrow Diseases
Hematologic Neoplasms
Hemic and Lymphatic Disease, Unclassified
Indicated drugs: Tretinoin

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

Which approved drugs for FAB classification M3 Acute Promyelocytic Leukemia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account